Skip to main content

Advertisement

Log in

Uncoupling Protein 2 Involved in Protection of Glucagon–like Peptide 2 in Small Intestine with Ischemia–Reperfusion Injury in Mice

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Glucagon-like peptide 2 (GLP-2) is an intestinal epithelium-specific growth factor. However, its protective effects and related mechanism on the small intestine injured by ischemia–reperfusion (I/R) in mice remain unclear. This study aimed to reveal the effects of GLP-2 and its functional relationship with uncoupling protein 2 (UCP2) on the small intestine after I/R injury in mice. Male Balb/c mice were given GLP-2 (250 μg/kg/day, ip) for 3 days and underwent 30 min of superior mesenteric artery occlusion followed by 1 hr of reperfusion on day 4. Histological damage, bacterial translocation, diamine oxidase, and malondialdehyde level were assessed, and UCP2 expression was measured by immunohistochemistry and Western blot. GLP-2 attenuated the intestinal histological damage caused by I/R and increased the villous height by 28% and the crypt depth by 10%, respectively. Compared to the I/R group, diamine oxidase activity was increased, the incidence of bacterial translocation and malondialdehyde level were decreased, and UCP2 expression was increased in GLP-2-treated mice. GLP-2 protected the small intestine from I/R injury and increased UCP2 expression. These results suggested that effects of GLP-2 should be related to the upregulation of mitochondrial UCP2, which antagonized reactive oxygen species production.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Swank GM, Deitch EA: Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 20(4):411–417, 1996

    PubMed  CAS  Google Scholar 

  2. Sheth P, Seth A, Thangavel M, Basuroy S, Rao RK: Epidermal growth factor prevents acetaldehyde-induced paracellular permeability in Caco-2 cell monolayer. Alcohol Clin Exp Res 28(5):797–804, 2004

    PubMed  CAS  Google Scholar 

  3. Chen K, Okuma T, Okamura K, Tabira Y, Kaneko H, Miyauchi Y: Insulin-like growth factor-I prevents gut atrophy and maintains intestinal integrity in septic rats. JPEN J Parenter Enteral Nutr 19(2):119–124, 1995

    PubMed  CAS  Google Scholar 

  4. Drucker DJ, Erlich P, Asa SL, Brubaker PL: Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 93(15):7911–7916, 1996

    PubMed  CAS  Google Scholar 

  5. Tsai CH, Hill M, Asa SL, Brubaker PL, Drucker DJ: Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 273(1, Pt 1):E77–E84, 1997

    PubMed  CAS  Google Scholar 

  6. Benjamin MA, McKay DM, Yang PC, Cameron H, Perdue MH: Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut 47(1):112–119, 2000

    PubMed  CAS  Google Scholar 

  7. Scott RB, Kirk D, MacNaughton WK, Meddings JB: GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol 275(5, Pt 1):G911–G921, 1998

    PubMed  CAS  Google Scholar 

  8. Drucker DJ, Yusta B, Boushey RP, DeForest L, Brubaker PL: Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. Am J Physiol 276(1, Pt 1):G79–G91, 1999

    PubMed  CAS  Google Scholar 

  9. Alavi K, Schwartz MZ, Palazzo JP, Prasad R: Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2. J Pediatr Surg 35(6):847–851, 2000

    PubMed  CAS  Google Scholar 

  10. Tavakkolizadeh A, Shen R, Abraham P, et al.: Glucagon-like peptide 2: A new treatment for chemotherapy-induced enteritis. J Surg Res 91(1):77–82, 2000

    Article  PubMed  CAS  Google Scholar 

  11. Fleury C, Sanchis D: The mitochondrial uncoupling protein-2: current status[J] . Int J Biochem Cell Biol 31(11):1261–1278, 1999

    PubMed  CAS  Google Scholar 

  12. Fleury C, Neverova M, Collins S, et al.: Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15(3):269–272, 1997

    Article  CAS  PubMed  Google Scholar 

  13. Duval C, Negre-Salvayre A, Dogilo A, Salvayre R, Penicaud L, Casteilla L: Increased reactive oxygen species production with antisense oligonucleotides directed against uncoupling protein 2 in murine endothelial cells. Biochem Cell Biol 80(6):757–764, 2002

    PubMed  CAS  Google Scholar 

  14. Arsenijevic D, Onuma H, Pecqueur C, et al.: Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26(4):435–439, 2000

    Article  CAS  PubMed  Google Scholar 

  15. Echtay KS, Roussel D, St-Pierre J, et al.: Superoxide activates mitochondrial uncoupling proteins. Nature 415(6867):96–99, 2002

    PubMed  CAS  Google Scholar 

  16. Kouris GJ, Liu Q, Rossi H, et al.: The effect of glucagon-like peptide 2 on intestinal permeability and bacterial translocation in acute necrotizing pancreatitis. Am J Surg 181(6):571–575, 2001

    PubMed  CAS  Google Scholar 

  17. Li JY, Sun D, Lu Y, et al.: Change in intestinal function in sepsis in rat. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16(6):352–354, 2004 (Chinese)

    PubMed  Google Scholar 

  18. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 72:248–254, 1976

    Article  CAS  PubMed  Google Scholar 

  19. Taniguchi E, Harada M, Kawaguchi T, et al.: Expression of uncoupling protein-2 in biliary epithelial cells in primary biliary cirrhosis. Liver 22(6):451–458, 2002

    PubMed  Google Scholar 

  20. Pecqueur C, Alves-Guerra MC, Gelly C, et al.: Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J Biol Chem 276(12):8705–8712, 2001

    Article  PubMed  CAS  Google Scholar 

  21. Dowdall JF, Winter DC, Bouchier-Hayes DJ: Inosine modulates gut barrier dysfunction and end organ damage in a model of ischemia-reperfusion injury. J Surg Res 108(1):61–68, 2002

    PubMed  CAS  Google Scholar 

  22. Eror AT, Stojadinovic A, Starnes BW, Makrides SC, Tsokos GC, Shea-Donohue T: Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin Immunol 90(2):266–275, 1999

    PubMed  CAS  Google Scholar 

  23. Zhang C, Sheng ZY, Hu S, Gao JC, Yu S, Liu Y: The influence of apoptosis of mucosal epithelial cells on intestinal barrier integrity after scald in rats. Burns 28(8):731–737, 2002

    PubMed  Google Scholar 

  24. Drucker DJ: Glucagon-like peptides. Diabetes 47(2):159–169, 1998

    CAS  PubMed  Google Scholar 

  25. Rajeevprasad R, Alavi K, Schwartz MZ: Glucagonlike peptide-2 analogue enhances intestinal mucosal mass and absorptive function after ischemia-reperfusion injury. J Pediatr Surg 35(11):1537–1539, 2000

    PubMed  CAS  Google Scholar 

  26. Prasad R, Alavi K, Schwartz MZ: Glucagon-like peptide 2 analogue enhances intestinal mucosal mass following ischemia and reperfusion. J Pediatr Surg 35(2):357–359, 2000

    PubMed  CAS  Google Scholar 

  27. Peng X, Yan H, You Z, Wang P, Wang S: Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients. Burns 30(2):135–139, 2004

    PubMed  Google Scholar 

  28. Chang T, Lu R, Tsai L: Glutamine ameliorates mechanical obstruction-induced intestinal injury. J Surg Res 95(2):133–140, 2001

    PubMed  CAS  Google Scholar 

  29. Prabhu R, Thomas S, Balasubramanian KA: Oral glutamine attenuates surgical manipulation-induced alterations in the intestinal brush border membrane. J Surg Res 115(1):148–156, 2003

    PubMed  CAS  Google Scholar 

  30. Ikeda S, Zarzaur BL, Johnson CD, Fukatsu K, Kudsk KA: Total parenteral nutrition supplementation with glutamine improves survival after gut ischemia-reperfusion. JPEN J Parenter Enteral Nutr 26(3):169–173, 2002

    Article  PubMed  CAS  Google Scholar 

  31. Negre-Salvayre A, Hirtz C, Carrera G, et al.: A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J 11(10):809–815, 1997

    PubMed  CAS  Google Scholar 

  32. Argiles JM, Busquets S, Lopez-Soriano FJ: The role of uncoupling proteins in pathophysiological states. Biochem Biophys Res Commun 293(4):1145–1152, 2002

    PubMed  Google Scholar 

  33. Richard D, Clavel S, Huang Q, Sanchis D, Ricquier D: Uncoupling protein 2 in the brain: distribution and function. Biochem Soc Trans 29 (Pt 6):812–817, 2001

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuan Zou PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guan, L., Gong, D., Tian, N. et al. Uncoupling Protein 2 Involved in Protection of Glucagon–like Peptide 2 in Small Intestine with Ischemia–Reperfusion Injury in Mice. Dig Dis Sci 50, 554–560 (2005). https://doi.org/10.1007/s10620-005-2474-3

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-2474-3

Keywords:

Navigation